Literature DB >> 19127993

Solid-phase synthesis of 1,3,6-trisubstituted-1H-thiazolo[4,5-c][1,2]thiazin-4(3H)one-2,2-dioxide derivatives using traceless linker.

Taeho Lee1, Ji-Hoon Park, Moon-Kook Jeon, Young-Dae Gong.   

Abstract

A new solid-phase route for preparation of 1,3,6-trisubstituted-1H-thiazolo[4,5-c][1,2]thiazin-4(3H)one-2,2-dioxide derivatives is described. Our synthetic route is begun with a thiazole resin and relies on the sulfonamide formation, Mitsunobu-type N-alkylation, cyclization, and nucleophilic substitution methodology cleavage on a solid support. The strategy permits the incorporation of three points of diversity into the thiazolo[4,5-c][1,2]thiazine ring system in good overall yields.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19127993     DOI: 10.1021/cc8001684

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  4 in total

Review 1.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

Authors:  Roland E Dolle; Bertrand Le Bourdonnec; Karin Worm; Guillermo A Morales; Craig J Thomas; Wei Zhang
Journal:  J Comb Chem       Date:  2010-10-05

2.  CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.

Authors:  Zhexue Wu; Doohyun Lee; Jeongmin Joo; Jung-Hoon Shin; Wonku Kang; Sangtaek Oh; Do Yup Lee; Su-Jun Lee; Sung Su Yea; Hye Suk Lee; Taeho Lee; Kwang-Hyeon Liu
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

3.  Design and Synthesis of a Novel 4-aryl-N-(2-alkoxythieno [2,3-b]pyrazine-3-yl)-4-arylpiperazine-1-carboxamide DGG200064 Showed Therapeutic Effect on Colon Cancer through G2/M Arrest.

Authors:  Eun-Sil Lee; Nayeon Kim; Joon Hee Kang; Aizhan Abdildinova; Seon-Hyeong Lee; Myung Hwi Lee; Nam Sook Kang; Tae-Sung Koo; Soo-Youl Kim; Young-Dae Gong
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-20

4.  Traceless solid-phase synthesis and β-turn propensity of 1,3-thiazole-based peptidomimetics.

Authors:  Aizhan Abdildinova; Young-Dae Gong
Journal:  RSC Adv       Date:  2021-01-04       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.